C4 Therapeutics (CCCC) EBIT (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.05% |
| Dec 31, 2025 | 32.74% |
| Sep 30, 2025 | -20.74% |
| Jun 30, 2025 | 2.27% |
| Mar 31, 2025 | 22.66% |
| Dec 31, 2024 | -33.51% |
| Sep 30, 2024 | -31.72% |
| Jun 30, 2024 | 33.45% |
| Mar 31, 2024 | 13.92% |
| Dec 31, 2023 | -34.59% |
| Sep 30, 2023 | 25.98% |
| Jun 30, 2023 | -3.70% |
| Mar 31, 2023 | 5.39% |
| Dec 31, 2022 | -17.87% |
| Sep 30, 2022 | -18.64% |
| Jun 30, 2022 | 12.70% |
| Mar 31, 2022 | -105.63% |
| Dec 31, 2021 | 37.10% |
| Sep 30, 2021 | -9.67% |
| Jun 30, 2021 | -7.84% |
| Mar 31, 2021 | -8.50% |
| Dec 31, 2020 | -3.02% |
| Sep 30, 2020 | -68.98% |
| Jun 30, 2020 | 11.99% |
| Mar 31, 2020 | -17.52% |
| Dec 31, 2019 | -4.98% |